|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2007-2-5
|
|
pubmed:abstractText |
A vigorous T-cell response is essential for the resolution of HCV infection. It is modified by co-stimulatory molecules that attenuate T-lymphocyte responses by binding to CTLA4. We investigated whether CTLA4 single nucleotide polymorphisms are associated with the resolution of infection or with the course of disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/CTLA-4 Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/CTLA4 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2a
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:BergThomasT,
pubmed-author:BergkAlexandraA,
pubmed-author:HalangkJulianeJ,
pubmed-author:HinrichsenHolgerH,
pubmed-author:NeuhausPeterP,
pubmed-author:NeumannKonradK,
pubmed-author:PuhlGeroG,
pubmed-author:SchottEckartE,
pubmed-author:TinjalaSebastianS,
pubmed-author:TuboiSS,
pubmed-author:WeichViolaV,
pubmed-author:WiedenmannBertramB,
pubmed-author:WittHeikoH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
372-80
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17150279-Adolescent,
pubmed-meshheading:17150279-Adult,
pubmed-meshheading:17150279-Aged,
pubmed-meshheading:17150279-Aged, 80 and over,
pubmed-meshheading:17150279-Antigens, CD,
pubmed-meshheading:17150279-Antigens, Differentiation,
pubmed-meshheading:17150279-Antiviral Agents,
pubmed-meshheading:17150279-CTLA-4 Antigen,
pubmed-meshheading:17150279-Drug Therapy, Combination,
pubmed-meshheading:17150279-Female,
pubmed-meshheading:17150279-Hepacivirus,
pubmed-meshheading:17150279-Hepatitis C, Chronic,
pubmed-meshheading:17150279-Humans,
pubmed-meshheading:17150279-Interferon-alpha,
pubmed-meshheading:17150279-Liver Cirrhosis,
pubmed-meshheading:17150279-Male,
pubmed-meshheading:17150279-Middle Aged,
pubmed-meshheading:17150279-Polyethylene Glycols,
pubmed-meshheading:17150279-Polymorphism, Single Nucleotide,
pubmed-meshheading:17150279-Recombinant Proteins,
pubmed-meshheading:17150279-Ribavirin,
pubmed-meshheading:17150279-Sex Characteristics,
pubmed-meshheading:17150279-T-Lymphocytes,
pubmed-meshheading:17150279-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection.
|
|
pubmed:affiliation |
Department of Hepatology and Gastroenterology, CVK, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
